Scholarly Index
Dana E. Rathkopf
Memorial Sloan Kettering Cancer Center; 27,791 total citations; 317 total publications; best world rank #57
Memorial Sloan Kettering Cancer Center
27,791Total citations
317Total publications
57H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Radiopharmaceutical Chemistry and Applications | Lifetime | 190 | US 93 | 98.68 |
| Prostate Cancer Treatment and Research | Lifetime | 325 | US 189 | 99.02 |
| Cancer, Lipids, and Metabolism | Lifetime | 572 | US 285 | 97.90 |
| PARP inhibition in cancer therapy | Lifetime | 415 | US 199 | 95.28 |
| Prostate Cancer Treatment and Research | 2021-2025 | 57 | US 24 | 99.36 |
| PARP inhibition in cancer therapy | 2021-2025 | 65 | US 29 | 97.82 |
| Radiopharmaceutical Chemistry and Applications | 2021-2025 | 116 | US 37 | 96.99 |
| Cancer, Lipids, and Metabolism | 2021-2025 | 623 | US 124 | 87.46 |
| Prostate Cancer Diagnosis and Treatment | 2021-2025 | 876 | US 252 | 91.65 |
| Cancer Treatment and Pharmacology | 2021-2025 | 665 | US 233 | 88.03 |
| Hormonal and reproductive studies | 2021-2025 | 701 | US 163 | 78.53 |